Ipsen plans to expand its commitment, investment and commercial presence in the U.S. market through a series of moves. The company will make a multi-million dollar capital investment in its Milford, MA R&D and technical operations facility, and will relocate U.S. Operations headquarters from Brisbane, CA, to Bridgewater, NJ, in order to enhance the North American commercial organization. The existing 77,000-sq.-ft. Milford facility serves as a center for Ipsen’s U.S.-based peptide and toxin...